Uniting industry leaders to foster innovation, investment, and partnership opportunities to drive the commercialisation of cutting-edge advanced wound care products.
BOOK NOW
120+ senior decision makers to network with, meaning you’ll meet the right partners for your business and R&D needs
10 roundtables deep-diving into the most pressing industry-specific challenges, including: Reimbursement, Regulations, IP & Patents, the MDD to MDR Transition
A brand-new innovation showcase, highlighting the most cutting-edge products, services and technologies poised to transform wound care
SmartTRAK is today's leading market insights provider for the global Wound Care market. This session will provide key insights into the market size, growth and the latest trends to help wound care companies navigate this complex market.
This presentation will outline the unique dynamics and considerations associated with entering the US market for advanced wound care innovation and will address the various challenges and opportunities to consider, highlighting successful examples of US launches. Topics covered will include understanding FDA approval, exploring the opportunity for reimbursement and market potential, and considering cultural nuances.
This panel discussion will deep dive into the predominant regulatory framework governing medical devices in Europe; MDR. Focusing on the transition from MDD to MDR, experts will outline the impact in Europe, including the stricter criteria for clinical evidence, post-market surveillance, the implications for manufacturers, and the increased scrutiny of high-risk devices, comparing these new criteria to the FDA’s. The discussion will explore key timelines, dates, and assessments, leaving the audience with a deeper understanding of the European regulatory landscape.
At AOTI, we are helping all people with chronic conditions get back to living their lives to the fullest. We do this by enhancing access to care, improving clinical outcomes and quality of life, and advancing health equity. AOTI is recognized as a leader in wound care technology around the world and is a founding member of the American Diabetes Association’s - Amputation Prevention Alliance. Our unique multi-modality Topical Wound Oxygen (TWO2) therapy has been proven through Randomized Controlled Trial and Real-World Evidence studies to significantly reduce both Hospitalizations and Amputations over 12 months. Using a combination of non-contact cyclical compression, humidification, and high-pressure delivery of oxygen, AOTI’s TWO2 therapy has shown to provide more effective and durable complete healing in a variety of different wound types, including Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers. TWO2 can be administered in any clinical setting or self-administered by the patient at home, overcoming common barriers to access and compliance, thus helping to advance health equity, while improving outcomes and reducing costs.
WoundCareWeekly.com is the world’s most comprehensive source of all things wound care, including events, news, white papers, studies and much more. We review close to 50 sources worldwide and post daily to the website and send the latest developments to our database of wound care pros and podiatrists weekly.
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
